SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

JP Morgan Maintains Neutral on Atara Biotherapeutics, Raises Price Target to $23

JP Morgan maintains Atara Biotherapeutics (NASDAQ:ATRA) with a Neutral and raises the price target from $22 to $23.

Benzinga · 05/12/2020 14:35

JP Morgan maintains Atara Biotherapeutics (NASDAQ:ATRA) with a Neutral and raises the price target from $22 to $23.